Human GLP-1R (GFP) HEK293 Reporter Cell

IP Friendly
Cat. No. / Size
Price
Availability
Qty
CHEK-ATF251-2Vials (1Vial X 2)
$15,200.00
CHEK-ATF251
Sub-Total :
$ 0
0
Add to Cart
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
0
Add to Cart
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Advantages
  • Genetically modified cell lines best reflect MOA (Mechanism of Action)
  • Higher activity and larger assay window for robust and reproducible cell-based bioassay
  • Comprehensive application data to support assay development and validation
  • Full tracible record, stringent quality control and validated cell passage stability
  • Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
  • Global commercial license assistance whenever regulatory filing is required
Description

The GLP-1R (GFP) HEK293 Reporter Cell was engineered to not only express CREB signaling response element, but also express the receptor full length human GLP-1R (Uniprot: P43220), which can drive GFP expressing systems by GLP-1R agonists or glucagon-like peptide 1 (GLP-1) stimulation. In the absence of agonist or GLP-1, the GLP-1R receptor is not activated and fluorescence signal is low. In the presence of agonist or GLP-1, the GLP-1R pathway-activated fluorescence can be detected in a dose-dependent manner.

Application

• Screen for agonists that can bind and activate GLP-1R

GLP1R Assay Principles

Growth Properties

Adherent

Selection Marker

Puromycin(2 μg/mL) + Hygromycin B(20 μg/mL)

Complete Growth Medium

DMEM + 10% FBS

Freeze Medium

Serum-free cell cryopreservation medium

Quantity

1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

Storage

Frozen in liquid nitrogen.

Mycoplasma Testing

Negative

Sterility Testing

Negative

Instructions for Use

See data sheet for detailed culturing and assay protocol.

ACRO Scientific Leadership Award

Supporting the scientists driving cell & gene therapy forward

Apply Now